跳至主要内容
临床试验/NCT03396094
NCT03396094已完成不适用

Pre- and Apnoeic High Flow Oxygenation for RApid Sequence Intubation in The Emergency Department (Pre-AeRATE): a Multicentre Randomised Controlled Trial

National University Hospital, Singapore1 个研究点 分布在 1 个国家目标入组 192 人开始时间: 2018年5月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
192
试验地点
1
主要终点
Lowest SpO2 achieved during first intubation attempt

研究概览

简要总结

Critically ill patients may need support for breathing by means of intubation, which is placement of a breathing tube into the windpipe. Rapid sequence intubation (RSI) is a method commonly used and is performed by administering medications to induce coma and muscle paralysis, followed by intubation to allow the ventilator to provide oxygen into the lungs. This procedure may be filled with potential complications.

During RSI, the patient stops spontaneous breathing after medically induced muscle paralysis occurs. Adequate oxygenation before and during paralysis is crucial to increase the reserves and prolong the time that oxygen levels in the blood remain above 90%, called the safe apnoea period. If the oxygen reserves are insufficient, the blood oxygen level will drop and can lead to permanent brain damage or even death.

This study aims to explore if delivering high-flow humidified oxygen at 60L/min via the nostrils would be superior to current methods of mask ventilation at 15L/min and nasal cannula at 15L/min, before and during paralysis respectively. If successful, this new method would allow for a longer safe apnoeic period and increase the chances for doctors to perform intubation successfully without the blood oxygen dropping below 90%.

详细描述

Maintaining adequate oxygenation during rapid sequence intubation (RSI) is imperative to prevent peri-intubation adverse events that can lead to increased duration of hospital and intensive care unit stay, or prolonged vegetative state requiring long-term institutionalisation.

Preliminary data from our emergency department (ED) airway registry revealed that 15% of patients experienced desaturation during intubation despite employing current best practices during RSI. In this multicentre randomised controlled trial in the ED, we aim to test the hypothesis that use of humidified high flow oxygenation via nasal cannula (HFNC) at 60L/min maintains higher oxygen saturation compared with current usual care using non-rebreather mask for preoxygenation and provides superior apnoeic oxygenation compared to the typical practice of 15L/min via standard nasal cannula.

The main goal of the study would be to improve on the lowest oxygen saturation during intubation, and thereby increase the safe apnoeic time during RSI. We plan to enrol adult patients who require rapid sequence intubation due to medical, surgical or traumatic conditions in the EDs of National University Hospital and Ng Teng Fong General Hospital.

Eligible patients will undergo block randomisation at equal ratio into 2 possible treatment combinations of pre-oxygenation and apnoeic oxygenation. The primary endpoint will be the lowest oxygen saturation achieved from time of administration of paralytic agent until quantitative end-tidal carbon dioxide is detected for the first intubation attempt.

Higher failure rates for intubation in unfasted patients in the ED compared to fasted patients in elective settings increase the risk of aspiration if re-oxygenation is required with bag-valve-mask ventilation. Prolongation of safe apnoea time through maintenance of oxygen saturation above 90% using HFNC oxygenation during RSI could potentially change current clinical practice, improve standard of care and translate to better outcomes for patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients aged 21 years and above, who require RSI due to medical, surgical and traumatic conditions, in the Emergency Departments of NUH and Ng Teng Fong General Hospital (NTFGH)

排除标准

  • •Patients with "do-not-resuscitate" orders
  • •Crash, awake or delayed sequence intubations
  • •Patients requiring non-invasive positive pressure ventilation
  • •Cardiac arrest
  • •Clinical suspicion or confirmed diagnosis of base of skull fractures or severe facial trauma that precludes nasal cannula placement
  • •Vulnerable patient populations (e.g. pregnant women, prisoners)

研究组 & 干预措施

Intervention

Experimental

High-flow nasal cannula oxygenation at 60L/min for pre-oxygenation and apnoeic oxygenation

干预措施: High-flow nasal cannulae (HFNC) oxygenation (Device)

Control

Active Comparator

Pre-oxygenation using non-rebreather mask and apnoeic oxygenation via nasal cannulae at 15L/min

干预措施: Non-rebreather mask and standard nasal cannula (Device)

结局指标

主要结局

Lowest SpO2 achieved during first intubation attempt

时间窗: From time of administration of paralytic agent until quantitative ETCO2 is detected post-intubation up to 45 minutes

Lowest SpO2 achieved during first intubation attempt which is defined as first attempt to insert endotracheal tube into oropharynx

次要结局

  • Incidence of SpO2 < 90%(From start of paralysis to successful intubation up to 45 minutes)
  • Peri-intubation adverse events(From induction to 15 minutes after intubation)
  • Number of attempts at intubation(Number of attempts required until successful intubation up to 45 minutes or termination of procedure, whichever is earlier)
  • Safe apnoea time during intubation(From start of paralysis to time when SpO2 drops to less than 90% up to 45 minutes)
  • Length of time to successful intubation(From induction until successful intubation as confirmed by detection of quantitative ETCO2 up to 45 minutes)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验